Correlation Between HLS Therapeutics and Crescita Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Crescita Therapeutics, you can compare the effects of market volatilities on HLS Therapeutics and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Crescita Therapeutics.

Diversification Opportunities for HLS Therapeutics and Crescita Therapeutics

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between HLS and Crescita is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Crescita Therapeutics go up and down completely randomly.

Pair Corralation between HLS Therapeutics and Crescita Therapeutics

If you would invest  238.00  in HLS Therapeutics on September 14, 2024 and sell it today you would earn a total of  2.00  from holding HLS Therapeutics or generate 0.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HLS Therapeutics  vs.  Crescita Therapeutics

 Performance 
       Timeline  
HLS Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Crescita Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Crescita Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Crescita Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

HLS Therapeutics and Crescita Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HLS Therapeutics and Crescita Therapeutics

The main advantage of trading using opposite HLS Therapeutics and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.
The idea behind HLS Therapeutics and Crescita Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets